Development of potent dual BET/HDAC inhibitors via pharmacophore merging and structure-guided optimization https://www.biorxiv.org/content/10.1101/2023.07.18.547334v1?med=mas
QOTO: Question Others to Teach Ourselves An inclusive, Academic Freedom, instance All cultures welcome. Hate speech and harassment strictly forbidden.